{"id":433333,"title":"Biosimilar biologic drugs - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-02","captureTimestamp":"2026-01-02T09:59:27.197000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/biosimilar-biologic-drugs.html?wbdisable=true","snippet":"Biosimilar biologic drugs A biosimilar biologic drug, or biosimilar, is a biologic drug that is highly similar to a biologic drug that was already authorized for sale (known as the reference biologic drug). Biosimilars may enter the market after the expiry of reference biologic…","rawSnapshotUrl":"/api/snapshots/raw/433333","browseUrl":"https://replay.healtharchive.ca/job-6/20260102095927/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/biosimilar-biologic-drugs.html?wbdisable=true#ha_snapshot=433333","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}